(1R,2R)-Ethyl 2-((tert-butoxycarbonyl)amino)cyclopentanecarboxylate, 95.0%, 1g

1,1,4,4,5,5,8,8-Octamethyl-1,2,3,4,5,6,7,8-octahydroanthracene, 97.0%, 10g

Tetrabutylammonium chloride hydrate, 95.0%, 1g

N-cyanobenzamide, 10g

5-(4-Bromophenyl)-5-oxovaleric acid, 95.0%, 250mg

(E)-1-(3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)prop-2-en-1-ol, 95.0%, 5g

4-Phenyl-1,2,3,6-tetrahydro-pyridine, 98.0%, 5g

tert-butyl 3-[(pentan-3-yl)amino]propanoate, 95.0%, 10g

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)ethanone, 95.0%, 1g

(7-Chloro-2-methyl-1H-indol-3-yl)-acetic acid, 95.0%, 250mg

Plan 4x/0.10 objective

(1R,2S)-2-[N-Benzyl-N-(mesitylenesulfonyl)amino]-1-phenylpropyl Propionate [Reagent for anti-selective asymmetric aldol reaction]>98.0%(HPLC)1g

trans-2-Hexen-1-yl Propionate>95.0%(GC)25mL